Femi Emmanuel Ayeni

Dr. Femi Emmanuel Ayeni

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2024 in Arthroplasty
Verified
Journal Article
Open access
PDF file
SASarang Agarwal
Sarang Agarwal
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
RSRami Sorial
Rami Sorial
Background: Mechanical alignment with total knee arthroplasty (TKA) has been widely used since the implantation of the first prosthetic knee. Multiple studies have reported 80% patient satisfaction with TKA. However, the reported patients’ dissatisfaction is believed to be caused by having to convert different knee alignments to neutral alignments. It is postulated that a change in the CPAK classification of knees leads to patient dissatisfaction. Thus, we hypothesized that a change in CPAK classification with robot-assisted TKA with mechanical alignment does not significantly lead to patient dissatisfaction. Methods: We retrospectively analyzed 134 patients who underwent robot-assisted mechanical alignment total knee arthroplasty (MA-TKA) using cementless implants and classified them into CPAK system pre- and post-operatively. One year after TKA surgery, we recorded binary responses to patients’ satisfaction with the outcome of surgery and analyzed if a change in CPAK classification is associated with the outcome of surgery. Results: We found that 125 out of 134 patients (93.28%) were happy with the outcome of surgery. CPAK classification was changed in 116 patients (86.57%) and maintained in 18 patients (13.43%). Our results also showed that 111 (95.7%) out of 116 patients who had a change in CPAK and 14 (77.8%) out of 18 patients who maintained their CPAK post-surgery were happy with the outcome of surgery (OR = 6.3, CI 1.741–25.17, P value = 0.019). Conclusion: We concluded that changing the patient’s native joint line and CPAK classification does not significantly change the outcome of surgery in terms of satisfaction. The dissatisfaction rate of 20% as published by previous researchers may be confounded by other reasons and not just due to changes in alignment and joint line.

8 July 2024 in Thyroid Research
Verified
Journal Article
Open access
PDF file
DCDominic Cooper
Dominic Cooper
RKRajneesh Kaur
Rajneesh Kaur
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
GEGuy D. Eslick
Guy D. Eslick
SESenarath Edirimanne
Senarath Edirimanne
Background: The incidence of hypothyroidism following hemithyroidectomy and risk factors associated with its occurrence are not completely understood. This systematic review investigated the incidence and risk factors for hypothyroidism, thyroxine supplementation following hemithyroidectomy as well as the course of post-operative hypothyroidism, including the time to hypothyroidism and incidence of transient hypothyroidism. Methods: Searches were conducted in MEDLINE, EMBASE, Scopus, and Cochrane library for studies reporting the incidence of hypothyroidism or thyroxine supplementation following hemithyroidectomy. Results: Sixty-six studies were eligible for inclusion: 36 reported risk factors, and 27 reported post-operative course of hypothyroidism. Median follow-up was 25.2 months. The pooled incidence of hypothyroidism was 29% (95% CI, 25-34%; P<0.001). Transient hypothyroidism occurred in 34% of patients (95% CI, 21-47%; P<0.001). The pooled incidence of thyroxine supplementation was 23% (95% CI, 19-27%; P<0.001), overt hypothyroidism 4% (95% CI, 2-6%, P<0.001). Risk factors for development of hypothyroidism included pre-operative thyroid stimulating hormone (TSH) (WMD, 0.87; 95% CI, 0.75-0.98; P<0.001), TSH ≥ 2 mIU/L (RR, 2.87; 95% CI, 2.43-3.40; P<0.001), female sex (RR, 1.19; 95% CI, 1.08-1.32; P=0.007), age (WMD, 2.29; 95% CI, 1.20-3.38; P<0.001), right sided hemithyroidectomy (RR, 1.35; 95% CI, 1.10-1.65, P=0.003), the presence of autoantibodies anti-TPO (RR, 1.92; 95% CI, 1.49-2.48; P<0.001), anti-Tg (RR, 1.53; 95% CI, 1.40-1.88; P<0.001), and Hashimoto’s thyroiditis (RR, 2.05; 95% CI, 1.57-2.68; P=0.001). Conclusion: A significant number of patients will develop hypothyroidism or require thyroxine following hemithyroidectomy. An awareness of patient risk factors and postoperative thyroid function course will assist in counselling patients on their risk profile and guiding management.

7 June 2023 in Arthroplasty
Verified
Journal Article
Open access
PDF file
NSNanchappan Selvanathan
Nanchappan Selvanathan
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
RSRami Sorial
Rami Sorial
Background: To ensure the success of total knee arthroplasty (TKA), precise bone cuts and a well-balanced soft tissue envelope are crucial. Soft tissue release may be necessary, subject to various factors. Therefore, documenting the type, frequency, and necessity of soft tissue releases can establish a benchmark for comparing different alignment techniques and philosophies and evaluating their outcomes. The purpose of this study was to demonstrate that robotic-assisted knee surgery requires minimal soft tissue release. Methods: We prospectively documented and retrospectively reviewed the soft tissue releases employed in securing ligament balance in the first 175 patients who received robotic-assisted TKAs at Nepean Hospital. ROSA was utilized in all surgeries with the aim of restoring mechanical coronal alignment, with a flexion gap balancing technique. Surgeries were performed between December 2019 to August 2021 by a single surgeon who used a standard medial parapatellar approach without a tourniquet, and the cementless persona prosthesis. All patients were followed up for a minimum of 6 months post-surgery. Soft tissue releases included any form of medial release for varus knee, posterolateral release for valgus knee and PCL fenestration or sacrifice. Results: There were 131 female and 44 male patients, aged between 48 to 89 years (average 60 years). The preoperative HKA ranged from 22 degrees varus to 28 degrees valgus, with 71% of patients presenting with a varus deformity. For the whole group, the no need for soft tissue release was documented in 123 patients (70.3%), small fenestrated releases of PCL in 27 (15.4%), sacrifice of PCL in 8 (4.5%), medial releases in 4 (2.3%) and posterolateral releases in 13 (7.4%). In 29.7% of patients in whom a soft tissue release was necessary for balance, over half were/received minor fenestrations of the PCL. Outcomes to date included no revisions or impending revisions, 2 MUAs (1%), and Oxford knee scores averaged 40 at 6 months. Conclusion: We concluded that Robot technology enhanced the precision of bone cuts and allowed for titration of required soft tissue releases to achieve optimal balance.

9 June 2023 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
JYJerry Yu
Jerry Yu
RKRajneesh Kaur
Rajneesh Kaur
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
GEGuy D. Eslick
Guy D. Eslick
SESenarath Edirimanne
Senarath Edirimanne
We performed a systematic review and meta-analysis of the literature regarding cardiovascular outcomes of differentiated thyroid cancer (DTC) patients who are on long term thyroid stimulating hormone suppression. Searches were carried out using Prisma guidelines in Medline, Embase, CENTRAL, CINAHL and Scopus databases. Eligible papers were those which investigated discrete cardiovascular clinical outcomes in TSH suppressed patients and meta-analysis of selected studies was performed using Revman 5.4.1. We found a total of 195 879 DTC patients with median length to follow up of 8.6 years (range 5–18.8 years). Analysis showed DTC patients to be at higher risk of atrial fibrillation (HR 1.58, 95% CI 1.40, 1.77), stroke (HR 1.14, 95% CI 1.09, 1.20) and all-cause mortality (HR 2.04, 95% CI 1.02, 4.07). However, there was no difference in risk of heart failure, ischemic heart disease or cardiovascular mortality. These findings suggest that degree of TSH suppression must be titrated to accommodate risk of cancer recurrence and cardiovascular morbidity.

23 March 2024 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
NSNanchappan Selvanathan
Nanchappan Selvanathan
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
RSRami Sorial
Rami Sorial
Several studies reported that20% of patients were unhappy with the outcome of their total knee arthroplasty (TKA). Having commenced robot assist TKA whilst maintaining the goal of implanting the prosthesis to a neutral mechanical axis, we reviewed our patients to find out if we also have a 20% rate of patients being unhappy with the outcome of their knee replacement surgery. We hypothesized that rate of patient satisfaction would be higher than 90% with robot-surgical assistant (ROSA) technique. The first 175 patients who underwent ROSA TKA were reviewed at a minimum of 1 year postoperatively. All TKAs were performed using ROSA technique with Persona cementless prosthesis aiming to restore neutral mechanical coronal alignment with flexion gap balancing. We investigated whether or not the patients were happy they had their knee replacement surgery and whether they were happy with the outcome. 165 (94%) of 175 patients, were contactable with 1 deceased and 9 uncontactable. From the 165 patients who participated in the study, 95% of patients were happy they had the surgery done and 93% were happy with the outcome of their knee replacement. A sub analysis showed that patients who had simultaneous bilateral TKA were significantly less likely to be happy than staged procedures (p < 0.05). Total knee replacement utilising robot technique with modern implants and aiming for mechanical coronal alignment of the implants to restore the mechanical axis with flexion gap balancing may result in > 90% of patients being happy with the outcome of their surgery.

24 April 2024 in Aesthetic Plastic Surgery
Verified
Journal Article
Open access
PDF file
GPGeorge Pappas
George Pappas
WKWilliam Karantanis
William Karantanis
FAFemi Emmanuel Ayeni
Femi Emmanuel Ayeni
SESenarath Edirimanne
Senarath Edirimanne
Background: Reduction mammoplasty and mastopexy are potentially complicated by prior breast irradiation as part of breast conserving therapy. Associated tissue changes with therapeutic irradiation have led to surgeons deciding the risks may outweigh potential benefit for those patients. A systematic review of the existing literature was performed to explore surgical outcomes of patients undergoing delayed bilateral reduction mammoplasty or mastopexy following unilateral breast irradiation as part of breast conserving therapy. Methods: Medline, PubMed and EMBASE were searched from 1990 to 2023 according to PRISMA guidelines. Studies were combined by the generic inverse variance method on the natural logarithms of rate ratios (RR) using a random effect model in Review manager 5.4.1. Results: Fifteen studies reported outcomes in 188 patients who underwent breast reduction (BR) following unilateral breast conserving surgery and radiotherapy. The median age at BR was 51.5 years (range 39–60), and median time since radiotherapy was 48 months (range 11.7–86). We compared outcomes for irradiated breast (IB) versus non-irradiated breast (NIB). Pooled results showed higher rate of major complications in the IB (RR 2.52, 95%CI 0.96–6.63, p=0.06), but not statistically significant. However, rate of minor complications was significantly higher in the IB (RR 3.97 95%CI 1.86-8.50, p<0.0004). Incidence of fat necrosis as a discrete complication was 2× higher in IB (RR 2.14 95%CI 0.85–5.35, p-value 0.10) compared to the NIB, but not significant. Conclusion: We found breast reduction to be safe with acceptable risk of major complications. However, the overall complication rate remains higher in IB compared to NIB. Level of Evidence III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of contents or the online Instructions to Authors www.springer.com/00266.